FDA Import Refusal BNI-0061346-1/101/1W — NAONAK UNIQUE VENTURE
The FDA refused shipment BNI-0061346-1/101/1W from NAONAK UNIQUE VENTURE (Ghana) on Sep 7, 2017. The refused product falls under Drugs and Biologics — AMPICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED). Cited charges: 16,3500,472,82 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 7, 2017
- Country
- Ghana
- Product Category
- Drugs and Biologics
- Product Code
- 56BCF07 AMPICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
- Charges
- 16,3500,472,82